Novo Holdings A/S - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$26,365,500
-7.0%
525,000
+17.0%
1.95%
-11.1%
Q2 2023$28,364,413
+40.5%
448,8040.0%2.19%
+64.6%
Q1 2023$20,191,692
+24.6%
448,804
+21.3%
1.33%
+31.6%
Q4 2022$16,209,700
-22.3%
370,000
+16.8%
1.01%
+1.7%
Q3 2022$20,866,000
+30.5%
316,6740.0%1.00%
+26.3%
Q2 2022$15,995,000
+10.1%
316,674
+39.2%
0.79%
+2.7%
Q1 2022$14,534,000
-31.1%
227,526
+15.5%
0.77%
-23.2%
Q4 2021$21,101,000
+4.2%
197,0000.0%1.00%
-4.7%
Q3 2021$20,254,000
+16.9%
197,0000.0%1.05%
+36.3%
Q2 2021$17,328,000
-9.5%
197,0000.0%0.77%
-2.8%
Q1 2021$19,154,000
-13.3%
197,0000.0%0.79%
-16.5%
Q4 2020$22,094,000
+1.4%
197,000
-16.2%
0.95%
-12.4%
Q3 2020$21,783,000
+8.8%
234,979
-8.5%
1.08%
-16.4%
Q2 2020$20,028,000
+46.2%
256,767
+9.6%
1.29%
+41.5%
Q1 2020$13,700,000
+0.2%
234,267
+37.3%
0.91%
+3.7%
Q4 2019$13,672,000
+9.0%
170,6670.0%0.88%
-59.0%
Q3 2019$12,539,000
-0.0%
170,667
+28.3%
2.15%
+22.3%
Q2 2019$12,544,000
+131.9%
132,976
+96.8%
1.76%
+119.6%
Q1 2019$5,409,00067,5670.80%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders